With telehealth adoption and the rise of digital solutions for specialty and prescription drugs, it’s time for pharma companies to take the opportunity presented by the acceleration of digital health — By Alex Baxter, André Heeg, Steve King, Amaryllis Liampoti, and Gunnar Trommer, BCG Digital Ventures The COVID-19 pandemic has triggered a shift to digital across industries, with store closures and lockdown measures leading to a step change in how consumers buy products. Online solutions that were just one channel in…